A common diabetes drug may be the next big thing for migraine relief. In a clinical study, obese patients with chronic ...

A diabetes medication that lowers brain fluid pressure has cut monthly migraine days by more than half, according to a new ...

Novo Nordisk’s drugs are being linked to an eye condition that can cause vision loss, while health tech companies made CNBC’s ...

The European Medicines Agency (EMA) has warned that popular weight-loss and diabetes drugs containing semaglutide — including ...

Semaglutide use may be increasing worldwide rates of ischemic optic neuropathy and retinal adverse events, a study suggests.

The following is a summary of “Association of Glucagon-like Peptide-1 Receptor Agonists with Optic Nerve and Retinal Adverse Events: A Population-Based Observational Study Across 180 Countries,” ...

Diabetic retinopathy, a common complication of diabetes, can damage the retina and lead to blindness. Early symptoms like floaters or blurred vision may be the first sign of diabetes.

Colombian billionaire Jaime Gilinski Bacal is open to selling his majority stake in British lender Metro Bank and has ...

Patients with diabetes who utilize GLP-1 RAs for 6 months or longer are twice as likely to develop neovascular age-related macular degeneration.

The European Medicines Agency’s safety committee found that an eye condition called NAION is a “very rare” side effect of semaglutide, a key ingredient in diabetes and obesity drugs. It could affect ...

Patients taking weight-loss and diabetes drugs Wegovy and Ozempic have an increased ... NAION is a disorder caused by reduced blood flow to the optic nerve in the eye, which can damage the nerve and ...

Diabetic retinopathy is the most common eye disease caused by diabetes. It happens when high blood sugar damages the small blood vessels in the retina, the part of the eye that senses light and ...